Creation of novel and effective therapeutics for small cell lung cancer by targeting PPAT as an inhibitor
- Department of Medical Sciences, Graduate School of Medical Sciences
The standard treatment for small cell lung cancer is cisplatin-based chemotherapy, which was approved in 1985. Until now, more than 30 years have passed since then, no specific and effective treatment [...]
Research keywords
- がん代謝
- 創薬
- 核酸合成